Michael Riedel

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

Norbert Müller, Markus Schwarz, Sandra Dehning et al. · Molecular Psychiatry · 2006 · 789 citations

Psychiatry, Add-on Pilot Study, Psychotropic Medication +8

Maturation of Human Embryonic Stem Cell–Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice

Alireza Rezania, Jennifer E. Bruin, Michael Riedel et al. · Diabetes · 2012 · 590 citations · Full text

Adult Stem Cell, Stem Cell Biology, Insulin Signaling +17

Beneficial Antipsychotic Effects of Celecoxib Add-On Therapy Compared to Risperidone Alone in Schizophrenia

Norbert Müller, Michael Riedel, Constanze Scheppach et al. · American Journal of Psychiatry · 2002 · 388 citations

Response and remission criteria in major depression – A validation of current practice

Michael Riedel, Hans‐Jürgen Möller, Michael Obermeier et al. · Journal of Psychiatric Research · 2010 · 279 citations

Psychopathology, Psychiatry, Depression Treatment +14

Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

Norbert Müller, Daniela Krause, Sandra Dehning et al. · Schizophrenia Research · 2010 · 254 citations

Celecoxib Treatment, Psychiatry, Psychotic Disorder +11